| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10219927 | European Urology | 2018 | 7 Pages |
Abstract
We assessed potential intermediate clinical endpoints prognostic for overall survival in a cohort of men receiving radiotherapy after prostatectomy. We identified the development of metastatic disease within 5 yr after treatment as the strongest predictor of overall survival.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
William C. Jackson, Krithika Suresh, Vasu Tumati, Steven G. Allen, Robert T. Dess, Simpa S. Salami, Arvin George, Samuel D. Kaffenberger, David C. Miller, Jason W.D. Hearn, Shruti Jolly, Rohit Mehra, Brent K. Hollenbeck, Ganesh S. Palapattu,